Page last updated: 2024-09-03

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Leukemia L 1210

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Leukemia L 1210 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, I; Khokhar, AR; Perez-Soler, R1
Khokhar, AR; Perez-Soler, R1
al-Baker, S; Khokhar, AR; Perez-Soler, R1
al-Baker, S; Brown, T; Khokhar, AR; Perez-Soler, R1
Khokhar, AR; Lopez-Berestein, G; Perez-Soler, R1

Other Studies

5 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Leukemia L 1210

ArticleYear
Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
    Cancer chemotherapy and pharmacology, 1996, Volume: 39, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liposomes; Magnetic Resonance Spectroscopy; Mice; Organoplatinum Compounds; Ovarian Neoplasms; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured

1996
Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
    Cancer research, 1992, Nov-15, Volume: 52, Issue:22

    Topics: Animals; Antineoplastic Agents; Biotransformation; Chemistry, Pharmaceutical; Dimyristoylphosphatidylcholine; Drug Carriers; Drug Stability; Hydrogen-Ion Concentration; Leukemia L1210; Lipid Bilayers; Lipids; Liposomes; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organoplatinum Compounds; Phosphatidylglycerols; Sodium Chloride; Structure-Activity Relationship

1992
Toxicity and efficacy studies on a series of lipid-soluble dineodecanoato(trans-R,R- and trans-S,S-1,2-diaminocyclohexane) platinum (II) complexes entrapped in liposomes.
    Anti-cancer drugs, 1992, Volume: 3, Issue:2

    Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Drug Stability; Leukemia L1210; Liposomes; Mice; Mice, Inbred Strains; Organoplatinum Compounds; Spectrophotometry; Stereoisomerism

1992
Chemical and biological studies on a series of lipid-soluble (trans-(R,R)- and -(S,S)-1,2-diaminocyclohexane)platinum(II) complexes incorporated in liposomes.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Dimyristoylphosphatidylcholine; Drug Carriers; Indicators and Reagents; Leukemia L1210; Liposomes; Mice; Molecular Structure; Organoplatinum Compounds; Phosphatidylglycerols; Structure-Activity Relationship

1991
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
    Cancer research, 1987, Dec-15, Volume: 47, Issue:24 Pt 1

    Topics: Animals; Antineoplastic Agents; Cell Line; Leukemia L1210; Liver Neoplasms; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Organoplatinum Compounds; Tissue Distribution; Tumor Cells, Cultured

1987